About this trial
The primary objective of this study is to quantify the clinical burden of Japanese Encephalitis (JE) and the asymptomatic circulation of JEV among Cambodian children, through two pediatric cohorts: non-febrile children at recruitment and children hospitalized with febrile neurological syndrome (FNS). Secondary objectives include estimating anti-JEV seropositivity rates, identifying individual risk factors and living conditions associated with JEV infection, characterizing clinical and biological profiles related to disease severity, and evaluating the role of deficiencies in interferon (IFN) response in severe JEV infections.
Eligibility criteria
Qualifiers
All children aged between 2 and 14 years.
No fever or history of fever in the past 14 days.
Consenting to return to the hospital for follow-up visits.
Consenting to blood sampling.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed